Skip to main content
TipRanks
Go Ultimate75% OFF

Eupraxia Pharmaceuticals (EPRX) Income Statement

82 Followers

Eupraxia Pharmaceuticals Income Statement

Last quarter (Q3 2026), Eupraxia Pharmaceuticals's total revenue was C$0.00. In Q3, Eupraxia Pharmaceuticals's net income was C$-15.38M. See Eupraxia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Mar 24Dec 22Dec 21
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
C$ -241.88KC$ -163.47KC$ -158.05KC$ -193.27KC$ -111.53K
C$ 38.86MC$ 25.54MC$ 28.37MC$ 23.38MC$ 18.38M
Depreciation and AmortizationC$ 241.88KC$ 171.72KC$ 117.41KC$ 190.42KC$ 111.53K
C$ -38.86MC$ -23.42MC$ -28.20MC$ -22.14MC$ -21.96M
C$ -39.11MC$ -25.71MC$ -28.53MC$ -23.58MC$ -18.47M
―C$ 1.20MC$ -1.08MC$ -341.08KC$ -4.90M
C$ -39.26MC$ -24.51MC$ -28.93MC$ -23.92MC$ -23.37M
C$ -39.25MC$ -24.28MC$ -28.15MC$ -23.26MC$ -22.99M
Per Share Metrics
Basic EPSC$ -1.05C$ -0.72C$ -1.19C$ -1.21C$ -1.61
Diluted EPSC$ -1.05C$ -0.72C$ -1.19C$ -1.21C$ -1.61
Weighted Average Shares Outstanding39.96M33.93M24.15M19.29M14.24M
Weighted Average Shares Outstanding (Diluted)39.96M33.93M24.15M19.29M14.24M

Currency in CAD

Eupraxia Pharmaceuticals Earnings and Revenue History

-45M-30M-15M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin